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To the Editor:
In their article, Menon and colleagues 1 confirm the well-known association between time delay and functional outcome after endovascular treatment in acute ischemic stroke. 2-3 They show that a short time interval between imaging and reperfusion increased the chance of achieving functional independency but did not find a significant relationship between symptom onset to imaging time and functional outcome. This finding seems contrary to our belief that every minute delay between onset of stroke and reperfusion, either before or after admission, has a negative effect on functional outcome. One explanation, also suggested by the authors, is the selection of patients in the study. Included patients were considered to be eligible for intraarterial treatment at the moment of presentation in the hospital and were expected to benefit from treatment based on clinical and imaging characteristics. Data on the patients not included in the study are not available, whereas the noninclusion of these patients (by intention or not) is likely to severely attenuate the effect of time before imaging.
Another explanation more easily verified in the data is that the effect of time from stroke to imaging on outcome was diluted by adjusting for ASPECTS (Alberta Stroke Program Early Computed Tomography Score). This measure of early ischemic damage is known to be strongly associated with time before imaging and with outcome. 4 An increased time to imaging will result in lower ASPECTS, so adjusting for it makes the effect of time on outcome disappear. This presumption is confirmed in our data of the MR CLEAN trial (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). 5 With adjustment for ASPECTS, the time interval from imaging to reperfusion seems to be more strongly associated with functional outcome (adjusted common odds ratio of 0.74 per 30 min, P<0.01) than time from stroke to imaging (adjusted common odds ratio 0.93, P=0.17). However, without adjustment for ASPECTS, both time from onset to imaging (adjusted common odds ratio 0.89, P=0.02) and time from imaging to reperfusion (adjusted common odds ratio 0.76, P<0.01) show a significant effect on functional outcome after intraarterial treatment in MR CLEAN, according to our expectations.
We conclude that it remains of critical importance to reduce any time delay between onset of stroke and reperfusion. Time from imaging to reperfusion can be used as a measure of in-hospital workflow, but we also have to remain focused on reducing prehospital time delay to increase the number of eligible patients and improve functional outcome after intra-arterial treatment. 
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